NORTH Bridge Venture Partners V a L.P., 10% Owner at Lyra Therapeutics, Inc. (LYRA), bought 4,739,334 shares at $4.22 ($20.0M) on 2022-04-12, disclosed to the SEC on 2022-04-14.
High-signal trade — passes our conviction filters but the AI narrative is still being generated. Check back shortly.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $4.22 | 527,806 | $2.2M | 11.1% |
| 2 | $4.22 | 527,806 | $2.2M | 11.1% |
| 3 | $4.22 | 765,010 | $3.2M | 16.1% |
| 4 | $4.22 | 765,010 | $3.2M | 16.1% |
| 5 | $4.22 | 1,076,851 | $4.5M | 22.7% |
| 6 | $4.22 | 1,076,851 |
| $4.5M |
| 22.7% |
| Total | $4.22 avg | 4,739,334 | $20.0M | 100% |